dbo:abstract
|
- Medrysone (INN, USAN) (brand names HMS, Medrocort, others; former developmental code name NSC-63278), also known as hydroxymethylprogesterone, methylhydroxyprogesterone, or hydroxymesterone, as well as 6α-methyl-11β-hydroxyprogesterone or 6α-methyl-11β-hydroxypregn-4-ene-3,20-dione, is a synthetic glucocorticoid that is or has been used in the treatment of inflammatory eye diseases. It has been discontinued in the United States. Although it is very similar in structure to progesterone, neither progestogenic nor androgenic activity has been demonstrated for or attributed to medrysone. (en)
- Il medrisone è un antinfiammatorio corticosteroide di sintesi, più precisamente un glucocorticoide, utilizzato in oftalmologia. Il farmaco viene venduto nella forma farmaceutica di sospensione oftalmica contenente l'1% di principio attivo. (it)
|
dbo:alternativeName
|
- HMS, Medrocort, others (en)
|
dbo:casNumber
| |
dbo:chEMBL
| |
dbo:drugbank
| |
dbo:fdaUniiCode
| |
dbo:kegg
| |
dbo:medlinePlus
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 6090 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:atcSuffix
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chembl
| |
dbp:chemspiderid
| |
dbp:drugbank
| |
dbp:h
| |
dbp:iupacName
|
- -17 (xsd:integer)
- 111214151617 (xsd:decimal)
|
dbp:iupharLigand
| |
dbp:kegg
| |
dbp:legalUsComment
| |
dbp:medlineplus
| |
dbp:o
| |
dbp:pregnancyUs
| |
dbp:pubchem
| |
dbp:routesOfAdministration
| |
dbp:smiles
|
- C[C@H]1C[C@H]2[C@@H]3CC[C@@H]CC (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- GZENKSODFLBBHQ-ILSZZQPISA-N (en)
|
dbp:synonyms
|
- NSC-63278; Hydroxymethylprogesterone; Methylhydroxyprogesterone; Hydroxymesterone; 6α-Methyl-11β-hydroxyprogesterone; 6α-Methyl-11β-hydroxypregn-4-ene-3,20-dione (en)
|
dbp:tradename
|
- HMS, Medrocort, others (en)
|
dbp:unii
| |
dbp:verifiedfields
| |
dbp:verifiedrevid
| |
dbp:watchedfields
| |
dbp:width
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Medrysone (INN, USAN) (brand names HMS, Medrocort, others; former developmental code name NSC-63278), also known as hydroxymethylprogesterone, methylhydroxyprogesterone, or hydroxymesterone, as well as 6α-methyl-11β-hydroxyprogesterone or 6α-methyl-11β-hydroxypregn-4-ene-3,20-dione, is a synthetic glucocorticoid that is or has been used in the treatment of inflammatory eye diseases. It has been discontinued in the United States. Although it is very similar in structure to progesterone, neither progestogenic nor androgenic activity has been demonstrated for or attributed to medrysone. (en)
- Il medrisone è un antinfiammatorio corticosteroide di sintesi, più precisamente un glucocorticoide, utilizzato in oftalmologia. Il farmaco viene venduto nella forma farmaceutica di sospensione oftalmica contenente l'1% di principio attivo. (it)
|
rdfs:label
|
- Medrisone (it)
- Medrysone (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |